1 not yet recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
Follow ACT100 Injection: new trials by email Literature Review of ACT100 Injection trials Research Report on ACT100 Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants.. ACT100 Injection, Placebo for ACT100 - Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus | Phase 1 | Not yet recruiting | Xiamen Amoytop Biotech Co., Ltd. | 48 | 2026-03-06 | 2026-02-13 |
Lupus Erythematosus, Cutaneous (1) · Lupus Erythematosus, Systemic (1)
Xiamen Amoytop Biotech Co., Ltd. (1)
Xiaohong Han (1)